Difference between revisions of "WSI22-127-Case-5"

From MGH Learn Pathology
Line 34: Line 34:
 
|subject=Z0FBQUFBQmpJNTBWUVZnVXFDMHVaVlZSandOQmMzdzNzZjNRX3R4U1liNUVBZEdnNkRKNTY1WXhveXpKTkdWM2pGdUtsRE5FV1cwTnc4TzUxc3pKVHBjYkZnQ0ppU2ZaUlNhSnBpdjVYQjFxSWM4TEFmMnBmcU09
 
|subject=Z0FBQUFBQmpJNTBWUVZnVXFDMHVaVlZSandOQmMzdzNzZjNRX3R4U1liNUVBZEdnNkRKNTY1WXhveXpKTkdWM2pGdUtsRE5FV1cwTnc4TzUxc3pKVHBjYkZnQ0ppU2ZaUlNhSnBpdjVYQjFxSWM4TEFmMnBmcU09
 
|reasonCode=MNF116 keratin
 
|reasonCode=MNF116 keratin
|view=show
+
|view=hide
 
|modality=mrxs
 
|modality=mrxs
 
}}
 
}}
Line 44: Line 44:
 
|subject=Z0FBQUFBQmpJNTBucXRtRFZMY0g5VlhJQ3hsOUl2dmtQSWRQQVdKZEJaZnNNRU03RHlsSXZkbEhDRFRuQ2NncXIzS3JEYkJDYk10eEVSYThiWm1vX2RWanRlakVrTDl6ZG02Y2hZSy1tbVVMa0xZZkVNZWpsWkU9
 
|subject=Z0FBQUFBQmpJNTBucXRtRFZMY0g5VlhJQ3hsOUl2dmtQSWRQQVdKZEJaZnNNRU03RHlsSXZkbEhDRFRuQ2NncXIzS3JEYkJDYk10eEVSYThiWm1vX2RWanRlakVrTDl6ZG02Y2hZSy1tbVVMa0xZZkVNZWpsWkU9
 
|reasonCode=Synaptophysin
 
|reasonCode=Synaptophysin
|view=show
+
|view=hide
 
|modality=mrxs
 
|modality=mrxs
 
}}
 
}}
Line 54: Line 54:
 
|subject=Z0FBQUFBQmpJNTAwOUd6WWxaRVF4V1h4WDVFUTZjX3VJZVI2SkpISWo0X0ZMM1BvdDBORXlZcnhpNnZLSnBORnpBOVlIcG16b2J2RVc4aVRhTTUtWnRUQ3BHTy1ndl9TenQ4bkJhNENLcFlSRFlNcTBpdi1XdTA9
 
|subject=Z0FBQUFBQmpJNTAwOUd6WWxaRVF4V1h4WDVFUTZjX3VJZVI2SkpISWo0X0ZMM1BvdDBORXlZcnhpNnZLSnBORnpBOVlIcG16b2J2RVc4aVRhTTUtWnRUQ3BHTy1ndl9TenQ4bkJhNENLcFlSRFlNcTBpdi1XdTA9
 
|reasonCode=Chromogranin A
 
|reasonCode=Chromogranin A
|view=show
+
|view=hide
 
|modality=mrxs
 
|modality=mrxs
 
}}
 
}}
Line 64: Line 64:
 
|subject=Z0FBQUFBQmpJNTFBSFZrUHpnd1dtTTF4X1hvdVNaQzlMazRvNUFFYmkxR0FWckpsczBEMHdNT0I4ZFoxWGgwd0lxWXBQMWNuM2VhMWVRQnh2ZEJIZ0VEVktNX2haQjR3RmlTMW9NdlVwS19PYVVKcjRYang4WTg9
 
|subject=Z0FBQUFBQmpJNTFBSFZrUHpnd1dtTTF4X1hvdVNaQzlMazRvNUFFYmkxR0FWckpsczBEMHdNT0I4ZFoxWGgwd0lxWXBQMWNuM2VhMWVRQnh2ZEJIZ0VEVktNX2haQjR3RmlTMW9NdlVwS19PYVVKcjRYang4WTg9
 
|reasonCode=Calretinin
 
|reasonCode=Calretinin
|view=show
+
|view=hide
 
|modality=mrxs
 
|modality=mrxs
 
}}
 
}}

Revision as of 10:52, September 16, 2022

WSI22-127-Case-5
60s female with a left nasal mass.
Olfactory neuroblastoma, Hyams grade 2-3 of 4.
October 26, 2022 1:15:00 AM